10/28/2013 IntegraGen Announces Study Results with Advanced Version of the ARISk Test Designed to Identify Risk of Autism in Broader Patient Population
10/23/2013 IntegraGen Reports 1st Half Results for 2013
10/14/2013 IntegraGen Obtains Exclusive License for microRNA which Predicts Therapy Outcomes in Metastatic Colorectal Cancer
07/08/2013 Publication of Results from study with 5-Gene Molecular Signature for Hepatocellular Carcinoma in Gastroenterology
07/08/2013 IntegraGen Announces 18% Growth in Revenues for H1 2013
04/15/2013 IntegraGen Announces Financial Results for 2012 Fiscal Year
02/11/2012 IntegraGen Announces Continued Growth in Genomic Services


12/20/2012 IntegraGen forms Autism Community Advisory Panel
11/28/2012 Publication of Results of Parental Survey in Clinical Pediatrics
07/12/2012 IntegraGen Announces Additional Financing
05/07/2012 IntegraGen Presents Autism Research at IMFAR
04/04/2012 IntegraGen Launches ARISk Autism Risk Assessment Test in U.S.
03/06/2012 IntegraGen Announces 45% Growth in Genomic Services in 2011